Our findings are in accordance with the OncoMine database (https://www.oncomine.org), where NR4A2 gene expression is shown to vary both within and among subtypes of gastric adenocarcinomas; being both higher and lower expressed compared to normal controls. This evidence concerns the gene NR4A2 and gastric adenocarcinoma.